- Home
- PGEN vs PLUG Comparison
PGEN vs PLUG Comparison
Compare PGEN & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGEN | PLUG |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2013 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PGEN | PLUG |
|---|---|---|
| Price | $6.39 | $1.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 19 |
| Target Price | ★ $13.65 | $3.41 |
| AVG Volume (30 Days) | 4.6M | ★ 42.9M |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.01 |
| EPS | ★ 0.03 | N/A |
| Revenue | $230,981,000.00 | ★ $709,919,000.00 |
| Revenue This Year | $2,365.68 | $15.45 |
| Revenue Next Year | $85.75 | $19.18 |
| P/E Ratio | $220.17 | ★ N/A |
| Revenue Growth | N/A | ★ 12.90 |
| 52 Week Low | $3.04 | $1.34 |
| 52 Week High | $8.98 | $4.33 |
Technical Indicators
Market Signals| Indicator | PGEN | PLUG |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 23.27 |
| Support Level | $6.08 | N/A |
| Resistance Level | $7.44 | $2.50 |
| Average True Range (ATR) | 0.44 | 0.08 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 2.37 | 6.78 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
About PLUG Plug Power Inc.
Plug Power Inc is building an end-to-end green hydrogen ecosystem, from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.